Monashee Investment Management LLC Dbv Technologies S.A. Transaction History

Monashee Investment Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 12, 2019	SELL	$8.57 - $10.72 $322,951 - $403,972	-37,684 Closed	0 $0
Q2 2019 Aug 07, 2019	BUY	$7.58 - $10.0 $285,644 - $376,840	37,684 New	37,684 $310,000
Q2 2018 Aug 10, 2018	SELL	$18.6 - $24.94 $1.86 Million - $2.49 Million	-100,000 Closed	0 $0
Q1 2018 May 10, 2018	BUY	$20.86 - $26.6 $2.09 Million - $2.66 Million	100,000 New	100,000 $2.31 Million

3.2K

Ticker DBVT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,776,992
Market Cap $792M
Description
DBV Technologies S.A., a clinical-stage biopharmaceutical company, engages in the research and development of epicutaneous immunotherapy products. Its lead product candidate is Viaskin Peanut, an immunotherapy product, which has completed Phase III clinical trial for the treatment of peanut allergies in 4 to 11 years of age children, adolescents...

Get notified when there are updates to the investment portfolio of Monashee Investment Management LLC, based on Form 13F filings with the SEC.

Stay updated on Monashee Investment Management LLC with notifications on news.